Regeneron Pharmaceuticals (REGN)

Change in Working Capital

-$161.10M

Quarterly · Period ending: · USD

REGN logo

REGN Change in Working Capital

Latest reported-$161.10M
REGN Quarterly Change in Working Capital (-$1.40M → -$161.10M)
High-resolution chart · PNG

REGN change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
-161,100,000
-77,400,000
5,900,000
625,000,000
-227,900,000
129,600,000
-86,400,000
468,000,000
-908,500,000
440,500,000
-61,400,000
-192,300,000
-81,300,000
240,900,000
382,000,000
-667,200,000
-781,300,000
823,200,000
-355,400,000
1,463,200,000
-2,484,900,000
-539,400,000
-35,400,000
-1,321,300,000
34,100,000
-181,000,000
-29,300,000
-300,100,000
-182,600,000
311,500,000
-249,344,000
-242,822,000
-237,376,000
32,542,000
-214,826,000
-92,181,000
-591,624,000
-27,902,000
79,504,000
248,891,000
125,590,000
-225,795,000
-1,263,000
553,200,000
-40,383,000
-281,727,000
-33,608,000
2,887,000
156,969,000
-106,009,000
119,065,000
-99,154,000
-83,037,000
-127,543,000
-113,297,000
-231,634,000
-191,653,000
-136,215,000
-28,578,000
-7,299,000
7,907,000
10,506,000
-46,805,000
181,043,000
-337,000
7,034,000
-23,125,000
-19,849,000
-3,398,000
-3,096,000
-14,899,000
-32,064,000
12,040,000
-17,511,000
48,312,000
14,435,000
13,481,000
11,239,000
75,745,000
4,108,000
-5,489,000
18,594,000
1,710,000
9,798,000
-11,237,000
27,516,000
-19,533,000
3,343,000
27,248,000
-69,801,000
-14,258,000
85,351,000
-15,195,000
28,428,000
2,135,000
6,336,000
-1,833,000
-3,058,000
8,739,000
-3,406,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.